BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38605095)

  • 21. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
    Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Genome Mapping for Chromosomal Aberrations Detection-False-Negative Results and Contributing Factors.
    Xu Y; Zhang Q; Wang Y; Zhou R; Ji X; Meng L; Luo C; Liu A; Jiao J; Chen H; Zeng H; Hu P; Xu Z
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
    Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and initial clinical evaluation of optical genome mapping in the diagnosis of structural variations].
    Hao N; Zhou J; Li MM; Luo WW; Zhang HZ; Qi QW; Jiang YL; Zhou XY; Yang K; Chen H; Pan HJ; Zhu JT; Liu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):632-639. PubMed ID: 35644979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel
    Tembrink M; Gerding WM; Wieczorek S; Mika T; Schroers R; Nguyen HP; Vangala DB; Nilius-Eliliwi V
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multisite Assessment of Optical Genome Mapping for Analysis of Structural Variants in Constitutional Postnatal Cases.
    Iqbal MA; Broeckel U; Levy B; Skinner S; Sahajpal NS; Rodriguez V; Stence A; Awayda K; Scharer G; Skinner C; Stevenson R; Bossler A; Nagy PL; Kolhe R
    J Mol Diagn; 2023 Mar; 25(3):175-188. PubMed ID: 36828597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers.
    Sahajpal NS; Mondal AK; Singh H; Vashisht A; Ananth S; Saul D; Hastie AR; Hilton B; DuPont BR; Savage NM; Kota V; Chaubey A; Cortes JE; Kolhe R
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A framework for the clinical implementation of optical genome mapping in hematologic malignancies.
    Levy B; Kanagal-Shamanna R; Sahajpal NS; Neveling K; Rack K; Dewaele B; Olde Weghuis D; Stevens-Kroef M; Puiggros A; Mallo M; Clifford B; Mantere T; Hoischen A; Espinet B; Kolhe R; Solé F; Raca G; Smith AC
    Am J Hematol; 2024 Apr; 99(4):642-661. PubMed ID: 38164980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses.
    Sahajpal NS; Barseghyan H; Kolhe R; Hastie A; Chaubey A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33799648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Application of Optical Genome Mapping (OGM) in Severe Short Stature Caused by Duplication of 15q14q21.3.
    Ke X; Yang H; Pan H; Jiang Y; Li M; Zhang H; Hao N; Zhu H
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of chromosomal structural variations in patients with recurrent spontaneous abortion using optical genome mapping.
    Rao H; Zhang H; Zou Y; Ma P; Huang T; Yuan H; Zhou J; Lu W; Li Q; Huang S; Liu Y; Yang B
    Front Genet; 2023; 14():1248755. PubMed ID: 37732322
    [No Abstract]   [Full Text] [Related]  

  • 33. Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia.
    Gao H; Xu H; Wang C; Cui L; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Zhang R; Li Z; Wang T
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
    Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
    J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical Genome Mapping Reveals Novel Structural Variants in Lymphoblastic Lymphoma.
    Xu H; Gao H; Wang C; Cheng X; Li Z; Lei C; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Duan Y; Wang T; Zhang R
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):e71-e82. PubMed ID: 38018972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Genome Mapping: A Revolutionary Tool for "Next Generation Cytogenomics Analysis" with a Broad Range of Diagnostic Applications in Human Diseases.
    Garcia-Heras J
    J Assoc Genet Technol; 2021; 47(4):191-200. PubMed ID: 34897113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms.
    Sahajpal NS; Mondal AK; Tvrdik T; Hauenstein J; Shi H; Deeb KK; Saxe D; Hastie AR; Chaubey A; Savage NM; Kota V; Kolhe R
    J Mol Diagn; 2022 Dec; 24(12):1279-1291. PubMed ID: 36265723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation.
    Ogiwara Y; Hattori A; Ikegawa K; Hasegawa Y; Kuroki Y; Miyado M; Fukami M
    Cytogenet Genome Res; 2022; 162(11-12):617-624. PubMed ID: 37231804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
    Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
    Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
    Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.